Industry Minister Ian Macfarlane congratulated Imugene Limited...

Industry Minister Ian Macfarlane congratulated Imugene Limited on being offered the grant. "Bird flu is deadly and unpredictable and a project to test vaccines to protect chickens from the virus will be an enormous breakthrough," Mr Macfarlane said. "The Australian Government is committed to helping companies such as Imugene develop vaccines which can be used globally and rid the world of a deadly threat. What is very encouraging is that the company is already primed to commence trials soon, with a completion date in early in 2007.” “This funding is important for Imugene and its shareholders as it strengthens our financial resources for product development,” said Dr Warwick Lamb, managing director of Imugene. “We are very grateful to the Commonwealth for this support and consider it an investment in the overall defence against bird flu outbreaks.” Perth Office Sydney Office
Level 20, Allendale Square Registered Office
77 St Georges Terrace Level 1, 14 – 20 Delhi Road
Perth WA 6000 North Ryde NSW 2113
Tel: +61 8 9440 2660 Tel:+61 2 9870 7330
Fax: +61 8 9440 2699 Fax:+61 2 9888 9338
ABN: 99 009 179 551 www.imugene.com
Imugene is matching the Commercial Ready Grant offer dollar-for-dollar. Milestone payments will be drawn over two years with the project period having begun on 1 October 2006. The trial vaccines utilise Imugene’s proven Fowl Adenoviral Delivery Vector. This technology delivers genetic material throughout a bird’s bloodstream to stimulate the immune system against the bird flu virus. The vaccines deliver only a portion of the virus genetic material instead of the whole virus. This makes the Imugene vaccines safe by preventing any chance of mutations or recombination with human flu viruses.